This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AbbVie made history in 2015 with its Parkinson’s disease infusion pump therapy Duopa, kicking off a trend of delivery system innovation in the space as drugmakers sought to avoid the common pitfall | The 24-hour Parkinson's disease therapy crossed the FDA finish line after an initial manufacturing-related rejection last year and another snub in (..)
Though GSK divested much of its oncology assets to Novartis in 2015, the company has built it back through a internal R&D and business development deals. GSK Senior Vice President, Global Head of Oncology, R&D Hesham Abdullah explained the company’s evolving cancer strategy in an interview during the J.P.
The accusations centered on the company's compensation of 86 female employees in 2015 and 2016. Department of Labor that it underpaid certain women who were employed at the company’s New York City headquarters. |
The Labor Department recently sued UnitedHealth Group subsidiary UMR, alleging that it wrongfully denied claims for emergency room services and urinary drug screenings since 2015.
Way back in 2015 a post on the Think with Google blog made the bold claim that, for marketers, consumer intent is more powerful than demographics: “Intent beats identity. GoodRx is a trusted, high-intent platform that helps providers and patients find what they need at the exact moment they are looking for something.
In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017. In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017.
In a 2015 study of 36 cancer drugs that had recently been approved, only 5 showed extended life. It’s about getting approvals and then making money and efficacy data be damned. The drug industry is driven by profits, not by patient’s needs. Here’s another example. That is reprehensible.
billion in 2015 and $208.9 Newly approved cancer drugs cost an average of $10,000 per month, with some as high as $30,000 per month. Just over a decade ago, the standard was $4,500. National costs for cancer care were estimated to be $190.2 billion in 2020 (2020 U.S. population.
2015 was a big year for The Brooks Group, and we’re going to brag a little. Top 7 Articles of 2015 . Our achievements this year included: Bronze Stevie Award for Sales Training Practice of the Year. Top 20 Sales Training Company, Training Industry. Top 20 Sales Training Company, Selling Power Magazine. 5000 Fastest Growing Company.
health plan for seniors in Florida improperly collected nearly $200 million in 2015 by overstating how sick some patients were, according to a new federal audit, which seeks to claw back the money. Pfizer is a company focused on one thing only: profits. It’s not just big pharma that’s raking in money. A Humana Inc.
. “Obesity is a serious global problem, and the suboptimal vaccine-induced immune responses observed in the obese population cannot be ignored,” pleaded researchers from the Mayo Clinic’s Vaccine Research Group in a 2015 study published in the journal Vaccine. And it’s getting worse.
Check out the top 7 sales leadership articles in 2015. In that spirit, we’ve collected 7 of the year’s most popular sales leadership posts to inspire you to focus on your own leadership development while improving the performance of your team. 5 Things High Performing Sales Managers Should Be Doing. Qualities of a Sales Leader.
The Defense Threat Reduction Agency, a division of the Department of Defense, provided more than $10 million of funding in 2013 and 2015 to Emory University, as research done by the nonprofit Knowledge Ecology International has revealed.
According to JAMA, “the estimated prevalence of diabetes increased significantly between 1999-2000 and 2017-2018, and only an estimated 21% of adults with diagnosed diabetes achieved all 3 risk factor control goals in 2015-2018” There are many reasons for obesity, from cultural to psychological, and although we would love it to go away (..)
Weber was subsequently appointed as CEO in April 2015, the company shared. He joined Takeda as CEO in April 2014. Two months later in June, he transitioned to the role of president and representative director. I am excited to guide Takeda through the next phase, stated Kim.
In 2015, the National Institute of Allergy and Infectious Diseases, an institute within the NIH, signed a cooperative R&D agreement with Moderna on basic research, including new vaccines. Additionally, Moderna used patents and non-exclusive rights that the U.S. government made available to them to make this COVID-19 vaccine.
A 2015 Commonwealth Fund brie f showed that — before the major provisions of the Affordable Care Act were introduced — the United States had worse outcomes and spent more on health care, primarily because of greater use of medical technology and higher prices, compared to other high-income countries.
In 2015, Alzheimer’s Therapeutics International found there was an estimated 46.8 According to Alzheimer’s Therapeutics International in 2015, 58 percent of people with dementia live in developing countries, but by 2050 this will rise to 68 percent. percent, and driven largely by collaboration of existing players, reach $6.8
million, his first big raise since 2015, thanks to incentive pay that jumped by about $1.2 million in 2020, more than double the number in 2015, according to health data company IQVIA. She later learned that her manager’s boss was behind the termination because she feared for her own job. ” Ouch. Annual U.S.
on cancer-related health care in 2015, and this amount is projected to grow to $246 billion by 2030—an increase of 34%. In 2018 cancer patients in the U.S. billion out of pocket for cancer treatments, including surgical procedures, radiation treatments, and chemotherapy drugs. Cancer also represents a significant portion of total U.S.
DRUG DEVELOPMENT based on targeted protein degradation (TPD) has progressed rapidly since the publication in 2015 of three landmark papers 1-3 that highlighted important early-stage breakthroughs with drug-like molecules in this area of research.
The study that emerged from scientists at the Yale Cancer Center, working in collaboration with researchers from Flatiron Health, concluded that there is no difference between the overall use of systemic anti-cancer therapy at the end-of-life stage since 2015.
A Forbes report published last year in the wake of the COP26 UN climate negotiations estimated that the 15 largest pharma manufacturers emitted 55% more carbon dioxide equivalents per million dollars of revenue than the automotive sector in 2015.
I joined in 2015 and have never looked back. I was first drawn to InCrowd inspired by the impact its work had on creating life-changing therapies. Trying to help customers do that in a more efficient and effective way really appealed to my desire to have a purpose in my work.
It maintains that Comirnaty infringes four patents – EP 1 857 122 B1, DE 20 2015 009 961 U1, DE 20 2021 003 575 U1 and DE 20 2015 009 974 U1 – which are the product of IP rights “accumulated over more than two decades of pioneering work in mRNA technology, which contributed to COVID-19 vaccine development.”
According to Glassdoor’s 2015 Employment Confidence Survey, about 60% of people report that benefits and perks are a significant factor in considering whether to accept a job offer. The survey also found that 80% of employees would choose additional benefits over a pay raise.
A 2015 review published in the Journal of Medical Internet Research , which analyzed the quality of mHealth apps, found that one app (the study didn’t call any apps by name) for bipolar disorder advised users experiencing a manic episode to “take a shot of hard liquor” to help them fall asleep.
The number of AI-based drug discovery strategic alliances has increased significantly, from just 10 in 2015 to 105 in 2021, with companies like BenevolentAI, Exscientia and Insilico Medicine featuring prominently in the dealmaking.
Moved down to the USA in 2015. Seventeen years in the pharmaceutical industry as a sales representative, sales manager, government affairs, market access, and training. Started a medical device distribution in 2012, covering all of Canada. Partner in 2 other medical device distributions. As he says, “Enjoying life under the sun!”
Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.
is a Private incorporated on 24 July 2015. Walk-Ins for Quality Control/ Production/ Production Documentation/ EHS On 7th Jan’ 2023. Job Description. Dasami Lab Pvt. It is classified as Non-govt. Company and registered at Register of Companies, Hyderabad.
In actual numbers, in 2015, poor diet was associated with over 52,200 colorectal cancer cases; over 14,400 mouth, pharynx and larynx cancers ; nearly 3,200 uterine cancers ; just over 3,000 cases of breast cancer in postmenopausal women; 2,000 kidney cancers ; nearly 1,600 stomach cancers ; and 1,000 liver cancers.
The first 3D-printed pharmaceutical , Spritam® (a levetiracetam tablet) was approved by the FDA in July 2015. Triastek has already received IND clearance from the FDA for its T19 and T20 products for rheumatoid arthritis (RA) and cardiovascular and clotting disorders, respectively.
Qdenga isn’t the first dengue vaccine to reach the market, but is free of the severe restrictions that have held back its only predecessor, Sanofi’s Dengvaxia, which was first approved for marketing in 2015, but was found to have a serious safety issue.
The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen.
The CDC had applied for patents back in 2006, and was later granted four in 2015. The government had called for Gilead to “respect the US patent system” and the taxpayer-funded research undertaken by the CDC, per the statement. The November 2019 lawsuit marked a further escalation in an existing dispute.
According to the survey, apprentice numbers are three times higher than 2015 statistics, across all skill levels from those entering the industry to master-qualified individuals. Pharmaceutical companies who contributed to the survey include AbbVie, AstraZeneca, Boehringer Ingelheim and GSK.
million) in 2015 , also for knowingly underpaying Medicaid rebates. . $125 million to be paid by Astellas Pharma US and Amgen Inc for illegally paying the Medicare co-pays for their own products, announced in 2019, and. agreements with AstraZeneca ($46.5 million) and Cephalon ($7.5
Founder: Eric Lefkofsky Year of establishment: 2015 Headquarters: Chicago, Illinois. Founders: Alice Zhang and Jason Chen Year of establishment: 2015 Headquarters: San Francisco, California. Founder: Travis Schneider Year of establishment: 2015 Headquarters: Downtown Santa Monica. Let’s get into it! 1. Tempus. Verge Genomics.
It is estimated that 28 million patients suffer from chronic cough, with 10 million patients globally and six million in the US and European Union (EU) suffering from RCC for over a year, according to a 2015 study. Therefore, the twice-daily oral medication has the potential to offer a breakthrough in the treatment landscape.
In 2015, the EMA and US Food and Drug Administration (FDA) approved Humira ® HCF, which contains adalimumab at a concentration of 100mg/ml. The proportion of patients who had at least a 75 percent reduction in symptoms after 16 weeks of treatment was 68 percent with Hyrimoz and 63 percent with Humira.
Collaboration between Vertex and CRISPR Therapeutics Vertex and CRISPR Therapeutics entered into a strategic research collaboration in 2015 focused on the use of CRISPR/Cas9 to discover and develop potential new treatments aimed at the underlying genetic causes of human disease.
It isn’t the first dengue vaccine to reach the market, but is free of the severe restrictions that have held back its only predecessor, Sanofi’s Dengvaxia , which was cleared for marketing in 2015.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content